» Articles » PMID: 28003275

Mutations in Hypodiploid Acute Lymphoblastic Leukemia

Overview
Specialty General Medicine
Date 2016 Dec 23
PMID 28003275
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Acute lymphoblastic leukemia (ALL) is an aggressive neoplasm of B- or T-lymphoid progenitors and is the commonest childhood tumor. ALL comprises multiple subtypes characterized by distinct genetic alterations, with stereotyped patterns of aneuploidy present in many cases. Although alterations of are common in many tumors, they are infrequent in ALL, with the exception of two ALL subtypes associated with poor outcome: relapsed disease and ALL with hypodiploidy. alterations are present in almost all cases of ALL with low hypodiploidy and are associated with alterations of the lymphoid transcription factor and the tumor-suppressor gene loci and Remarkably, more than half of mutations in low-hypodiploid ALL in children are present in nontumor cells, indicating that low-hypodiploid ALL is a manifestation of Li-Fraumeni syndrome. These findings have profound implications for our understanding of the genetic pathogenesis of hypodiploid ALL, suggesting that alteration of TP53 function may promote the distinctive aneuploidy characteristic of hypodiploid ALL. Moreover, the identification of hypodiploidy mandates offering testing for mutational status to patients and their relatives, with appropriate counseling and disease surveillance.

Citing Articles

From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.

Ahmadi S, Rahimian E, Rahimi S, Zarandi B, Bahraini M, Soleymani M Biomark Res. 2024; 12(1):137.

PMID: 39538363 PMC: 11565275. DOI: 10.1186/s40364-024-00676-9.


Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.

Zhao Y, Laird A, Roberts K, Yafawi R, Kantarjian H, DeAngelo D Blood Adv. 2024; 8(12):3226-3236.

PMID: 38607410 PMC: 11225676. DOI: 10.1182/bloodadvances.2023012430.


Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.

Arai H, Matsui H, Chi S, Utsu Y, Masuda S, Aotsuka N Int J Mol Sci. 2024; 25(1).

PMID: 38203823 PMC: 10779750. DOI: 10.3390/ijms25010652.


Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia.

Johansson K, Zimmerman M, Dmytrenko I, Gao F, Link D Leukemia. 2023; 37(12):2356-2366.

PMID: 37838759 PMC: 10681904. DOI: 10.1038/s41375-023-02057-x.


Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 induction.

Gasparoli L, Virely C, Tsakaneli A, Che N, Edwards D, Bartram J Haematologica. 2023; 109(4):1069-1081.

PMID: 37794795 PMC: 10985450. DOI: 10.3324/haematol.2023.283613.


References
1.
Cortes M, Wong E, Koipally J, Georgopoulos K . Control of lymphocyte development by the Ikaros gene family. Curr Opin Immunol. 1999; 11(2):167-71. DOI: 10.1016/s0952-7915(99)80028-4. View

2.
Lohmann D . RB1 gene mutations in retinoblastoma. Hum Mutat. 1999; 14(4):283-8. DOI: 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J. View

3.
Liang S, Clarke M . A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J Biol Chem. 1999; 274(46):32699-703. DOI: 10.1074/jbc.274.46.32699. View

4.
Heerema N, Nachman J, Sather H, Sensel M, Lee M, Hutchinson R . Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood. 1999; 94(12):4036-45. View

5.
Ramos M, Palacios J, Fournier B, Martinez J, Martinez-Lopez J, Conde M . Prognostic value of tumoral ploidy in a series of spanish patients with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2000; 122(2):124-30. DOI: 10.1016/s0165-4608(00)00290-9. View